Table 1.
Baseline characteristics of participants in a randomized controlled trial investigating the clinical efficacy of smartphone-based rehabilitation in individuals with chronic respiratory disease, conducted at Asan Medical Center, Seoul, Republic of Korea, 2023.
|
|
Total (n=70) | Intervention (n=46) | Control (n=24) | P value | U value | |||
| Age (years), median (IQR) | 65.5 (61.0-72.0) | 64.0 (60.0-68.0) | 67.5 (62.5-74.5) | .14 | 434.00 | |||
| Sex (male), n (%) | 48 (68.6) | 35 (76.1) | 13 (54.2) | .06 | N/Aa | |||
| Body weight (kg), median (IQR) | 61.0 (54.0-71.4) | 61.0 (54.0-71.8) | 59.0 (53.0-70.2) | .34 | 483.50 | |||
| Height (cm), median (IQR) | 167.0 (160.0-172.0) | 168.1 (161.0-172.0) | 164.5 (157.0-168.0) | .04 | 383.00 | |||
| BMI (kg/m2), median (IQR) | 23.0 (20.0-25.4) | 23.0 (19.8-25.3) | 22.9 (20.8-25.6) | .89 | 541.00 | |||
| Ever-smoker | 44 (62.9) | 32 (69.6) | 12 (50.0) | .11 | N/A | |||
| Respiratory disease, n (%) | .29 | N/A | ||||||
|
|
Obstructive | 53 (75.7) | 34 (73.9) | 19 (79.2) |
|
|
||
|
|
Bronchiectasis | 14 (20.0) | 11 (23.9) | 3 (12.5) |
|
|
||
|
|
Restrictive | 3 (4.3) | 1 (2.2) | 2 (8.3) |
|
|
||
| Comorbidities, n (%) | ||||||||
|
|
Diabetes mellitus | 9 (12.9) | 5 (10.9) | 4 (16.7) | .48 | N/A | ||
|
|
Hypertension | 20 (28.6) | 13 (28.3) | 7 (29.2) | .94 | N/A | ||
|
|
Dyslipidemia | 18 (25.7) | 11 (23.9) | 7 (29.2) | .64 | N/A | ||
|
|
Malignancy | 6 (8.6) | 2 (4.3) | 4 (16.7) | .17 | N/A | ||
|
|
Lung resection | 3 (4.3) | 1 (2.2) | 2 (8.3) | .27 | N/A | ||
aN/A: not applicable.